2-thiacephalosporanic acid derivs - useful as pharmaceuticals and intermediates
Cpds. of formula (I): (where Ra1 = Hb or an N-protecting gp; Rb1 = H or Ra1 + Rb1 = an org. ylidene gp. R2 = H or an ester-forming goup (RA2); R3 = H or a C-bonded org. gp. Ra and Rb are H or from a C-C bond) and their S-oxides and salts are prepd. by oxidn. of a cpd. (II) or acid treatment of a cpd...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English German |
Published |
15.09.1973
|
Edition | 1 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cpds. of formula (I): (where Ra1 = Hb or an N-protecting gp; Rb1 = H or Ra1 + Rb1 = an org. ylidene gp. R2 = H or an ester-forming goup (RA2); R3 = H or a C-bonded org. gp. Ra and Rb are H or from a C-C bond) and their S-oxides and salts are prepd. by oxidn. of a cpd. (II) or acid treatment of a cpd. (III) where X = opt. substd. methylene; R1o = H or a removable org. gp; RB2 = RA2 or an org. silyl orstannyl gp; Aco1 is a removable acyl gp) opt. followed by removal of the ylidene gp, saponification, esterification, conversion into the S-oxide and/or salt formation. (I) are pharmaceuticals or intermediates therefor e.g. (I) where Ra1 is an N-acyl deriv. of a penicillin or cephalosporin cpd. are broad-spectrum antibacterial. |
---|---|
AbstractList | Cpds. of formula (I): (where Ra1 = Hb or an N-protecting gp; Rb1 = H or Ra1 + Rb1 = an org. ylidene gp. R2 = H or an ester-forming goup (RA2); R3 = H or a C-bonded org. gp. Ra and Rb are H or from a C-C bond) and their S-oxides and salts are prepd. by oxidn. of a cpd. (II) or acid treatment of a cpd. (III) where X = opt. substd. methylene; R1o = H or a removable org. gp; RB2 = RA2 or an org. silyl orstannyl gp; Aco1 is a removable acyl gp) opt. followed by removal of the ylidene gp, saponification, esterification, conversion into the S-oxide and/or salt formation. (I) are pharmaceuticals or intermediates therefor e.g. (I) where Ra1 is an N-acyl deriv. of a penicillin or cephalosporin cpd. are broad-spectrum antibacterial. |
Author | WOODWARD,ROBERT BURNS |
Author_xml | – fullname: WOODWARD,ROBERT BURNS |
BookMark | eNqFy7sOwjAMheEMMHDpKyC_QAcuVWdUgbqxsFdW4qqWUieKE56fDOxMZ_i_szcbCUI787q0eWG0FBf0QWNIKGwBLTtwlPij0EJRmosHVKgqrVWXzBa9AooDlkxpJceYSY9mO9dAzW8P5vR8vIexpRgm0li_Qnkaxu527vr-fv0LvjfrN4Y |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | Verfahren zur Herstellung thiaheterocyclischer Verbindungen |
Edition | 1 |
ExternalDocumentID | CH541577A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CH541577A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:26:47 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CH541577A3 |
Notes | Application Number: CH19730004920 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19730915&DB=EPODOC&CC=CH&NR=541577A |
ParticipantIDs | epo_espacenet_CH541577A |
PublicationCentury | 1900 |
PublicationDate | 19730915 |
PublicationDateYYYYMMDD | 1973-09-15 |
PublicationDate_xml | – month: 09 year: 1973 text: 19730915 day: 15 |
PublicationDecade | 1970 |
PublicationYear | 1973 |
RelatedCompanies | CIBA-GEIGY AG |
RelatedCompanies_xml | – name: CIBA-GEIGY AG |
Score | 2.330865 |
Snippet | Cpds. of formula (I): (where Ra1 = Hb or an N-protecting gp; Rb1 = H or Ra1 + Rb1 = an org. ylidene gp. R2 = H or an ester-forming goup (RA2); R3 = H or a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
Title | 2-thiacephalosporanic acid derivs - useful as pharmaceuticals and intermediates |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19730915&DB=EPODOC&locale=&CC=CH&NR=541577A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb8IwDLYYm7bdNvZ-oBym3qqVNKFwqKbRgqpJPDSxiRtKkxYqoVLRsv39OR1sXLhFiWQ5lh07jj8H4ElGlkJPRE1LUG4yaTfMkFrMZC0r4lLKtsM13rk_aAYf7G3CJxWYbbEwZZ_Q77I5IlqURHsvyvM6-09i-WVtZf4cJji1fOmNXd9Qv3AxVNd2gxt-x-2Ohv7QMzzP9QJj8O5ydFSO83oAhxhDO7r2q_vZ0ZCUbNef9M7gaISk0uIcKiqqwYm3_XatBsf9zWs3DjeGl1_AkJrFPEFOs7lYLPVVVKSJJEImiihUoq-cmGSdR_F6QUROsvlupjonIlVEN4ZYlUARjC4vod7rjr3ARM6mfzKYesFmB_YVVNNlGt0AkbFq0xaGGExSxoXdYrFStqA0pM1QsvgWrvcQudu7cg-nWoy6IqLBH6BarNbRI7rdIqyXIvsBeduJVA |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbjPdj5IB6q-jSZOsOFWLtpgJ7CQ3EbUqTllWaumrt4O_jlg122S1KJMux7Nhx_DkAdzIwFHoiqhuCcp1Js6771GA6s4yASylbTZ7jnfuDhvfGnj_4Rwk-11iYok_od9EcES1Kor1nxXmd_Cex3KK2Mr33I5yaP3THtqupX7gYqmurzjW3bXdGQ3foaI5jO542eLU5Oqpm83EHdjG-tvIm-533dg5JSTb9SfcQ9kZIKs6OoKSCKlSc9bdrVdjvr167cbgyvPQYhlTPphFymkzFbJ5fRUUcSSJkpIhCJfpKiU6WaRAuZ0SkJJluZqpTImJF8sYQiwIogtHlCdS6nbHj6cjZ5E8GE8db7cA8hXI8j4NzIDJULWphiMEkZVyYFguVMgWlPm34koUXcLaFyOXWlVuoeON-b9J7GrxcwUEu0rw6os6voZwtlsENuuDMrxXi-wER2IxE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-thiacephalosporanic+acid+derivs+-+useful+as+pharmaceuticals+and+intermediates&rft.inventor=WOODWARD%2CROBERT+BURNS&rft.date=1973-09-15&rft.externalDBID=A&rft.externalDocID=CH541577A |